• Revenue of $260.0 million in the first quarter of 2021 increased 12.6% from revenue of $230.9 million for the comparable prior-year period, representing a backlog conversion rate of 16.9%.
• Net new business awards were $356.2 million in the first quarter of 2021, representing an increase of 44.2% from net new business awards of $246.9 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.37x.
• First quarter of 2021 GAAP net income was $43.3 million, or $1.14 per diluted share, versus GAAP net income of $29.0 million, or $0.76 per diluted share, for the comparable prior-year period. Net income margin was 16.7% and 12.5% for the first quarter of 2021 and 2020, respectively.
Sponsored
• EBITDA was $53.6 million for the first quarter of 2021, an increase of 32.1% from EBITDA of $40.6 million for the comparable prior-year period, resulting in an EBITDA margin of 20.6%.

CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2021.